Roche

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Merck
Keytruda
Melinta Therapeutics
Amag Pharmaceuticals
Palatin
Acer Therapeutics
Sanofi
Regeneron
Alexion
Pfizer
Roche
Navidea Biopharmaceuticals
Ascendis Pharma
Scholar Rock
Adaptive Biotechnologies
BridgeBio
IPOs
G Medical Innovations
Karuna
Morphic Therapeutics
Flag link:
Roche/Exelixis' Cotellic fizzles in pivotal melanoma study
Roche/Exelixis' Cotellic fizzles in pivotal melanoma study
Endpoints
Roche
Exelixis
Cotellic
Tecentriq
clinical trials
advanced melanoma
Flag link:
Look out, Bayer: Roche scores first global nod for targeted cancer drug Rozlytrek
Look out, Bayer: Roche scores first global nod for targeted cancer drug Rozlytrek
Fierce Pharma
Roche
Rozlytrek
Japan
cancer
Bayer Vitrakvi
Flag link:
Stepping on Roche's toes, Merck cuts into SCLC niche with second-line Keytruda OK
Stepping on Roche's toes, Merck cuts into SCLC niche with second-line Keytruda OK
Endpoints
Roche
Merck
SCLC
Keytruda
Flag link:
FDA Approves 20th Biosimilar, 5th for Roche’s Herceptin
FDA Approves 20th Biosimilar, 5th for Roche’s Herceptin
RAPS.org
FDA
biosimilars
Roche
Herceptin
Amgen
Kanjinti
Flag link:
FTC demands could mean months-long delay for Roche-Spark deal
FTC demands could mean months-long delay for Roche-Spark deal
Biopharma Dive
Roche
Spark Therapeutics
FTC
M&A
Flag link:
Roche touts phase 2 Gazyva data in lupus patients with a potentially fatal kidney complication
Roche touts phase 2 Gazyva data in lupus patients with a potentially fatal kidney complication
Fierce Pharma
Roche
FDA
lupus nephritis
Gazyva
Flag link:
Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout
Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout
Endpoints
Spark Therapeutics
Roche
FTC
UK
M&A
Flag link:
Roche snags first-in-class FDA nod for lymphoma drug Polivy
Roche snags first-in-class FDA nod for lymphoma drug Polivy
Fierce Pharma
FDA
Roche
Polivy
polatuzumab
diffuse large B-cell lymphoma
Flag link:
Roche's Xofluza scores trial win in flu prevention, providing sales hope as Tamiflu craters
Roche's Xofluza scores trial win in flu prevention, providing sales hope as Tamiflu craters
Fierce Pharma
Roche
Xofluza
clinical trials
influenza
Flag link:
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More
Xconomy
ASCO 2019
cancer
immunotherapy
diagnostics
Veracyte
Grail
Moderna Therapeutics
Amgen
Nektar Therapeutics
Blueprint Medicines
Merck
AstraZeneca
Roche
breast cancer
Flag link:
ASCO 2019 day three
ASCO 2019 day three
Pharmaforum
ASCO 2019
Merck
AstraZeneca
pancreatic cancer
Novartis
alpelisib
Roche
entrectinib
Flag link:
Bayer to work with Foundation Medicine on selecting cancer patients
Bayer to work with Foundation Medicine on selecting cancer patients
Reuters
Bayer
Foundation Medicine
Roche
cancer
Vitrakvi
genetic sequencing
Flag link:
[sponsored] Life Sciences Matchmaker SOURCE EXPLORER Passes 3,000-Client Milestone

[sponsored] Life Sciences Matchmaker SOURCE EXPLORER Passes 3,000-Client Milestone

CP Wire
life sciences
Source Explorer
Gilead Sciences
Roche
Mylan
Biogen
Genentech
AstraZeneca
Flag link:
[sponsored] Life Sciences Matchmaker SOURCE EXPLORER Passes 3,000-Client Milestone

life sciences
Source Explorer
Gilead Sciences
Roche
Mylan
Biogen
Genentech
AstraZeneca
Flag link:
Synlogic (SYBX) Enters Cancer Collaboration with Roche
Synlogic (SYBX) Enters Cancer Collaboration with Roche
Yahoo/Zacks.com
Synlogic
Roche
SYNB1891
Tecentriq
solid tumors
Flag link:
Roche's Chugai to set up new $1B+ lab in Yokohama, consolidating R&D
Roche's Chugai to set up new $1B+ lab in Yokohama, consolidating R&D
Endpoints
Chugai
Roche
Japan
R&D
Flag link:
Campaigners urge NHS to drop Roche acne drug
Campaigners urge NHS to drop Roche acne drug
Pharmaforum
Roche
Roaccutane
suicide
erectile dysfunction
acne
Flag link:
Roche, Bayer unveil brain tumor data for NTRK inhibitors ahead of ASCO
Roche, Bayer unveil brain tumor data for NTRK inhibitors ahead of ASCO
BioCentury
Roche
Bayer
brain cancer
entrectinib
Vitrakvi
Flag link:
AbbVie, Roche snag another CLL nod, this time for Venclexta-Gazyva
AbbVie, Roche snag another CLL nod, this time for Venclexta-Gazyva
Fierce Pharma
AbbVie
Roche
Venclexta
CLL
small lymphocytic leukemia
Flag link:

Pages